Furthermore, we demonstrated that inhibition of LAT1 by a specific inhibitor JPH203 prevents lymphoma cell proliferation, thus LAT1 can be a possible therapeutic target for NHL. Here, LAT is linked to non-Hodgkin lymphoma.